Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting
Neuro
Q’Apel Medical Announces U.S. FDA Clearance for the Zebra Neurovascular Access System and Prepares for Full U.S. Launch
Increasing rates of neurovascular interventions spark a need for reliable access and procedural versatility Company expands portfolio with a novel access catheter featuring a unique ID/OD ratio Purpose-built laser cut technology enables balanced delivery performance and stable support…
Brainomix and 3DR Labs Partner to Advance Stroke Care in the US Through Clinically Validated AI Imaging Solution
OXFORD, England and CHICAGO, Ill., June 24, 2025 /PRNewswire/ — Today, Brainomix, a pioneer in stroke artificial intelligence (AI) imaging solutions, and 3DR Labs, the market leader in medical imaging post-processing services, announced a new strategic partnership to support acute stroke…
ANACONDA Biomed Receives CE Mark for its ANA5 Funnel Catheter to Treat Ischemic Stroke
BARCELONA – June 18, 2025 – ANACONDA Biomed, a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has received CE Mark certification for its ANA5 Funnel Catheter. The CE marking confirms that the ANA5 device complies with the European Union’s health, […]
Crossroads Neurovascular, Inc. Announces FDA 510(k) Clearance for PATH BGC™, the World’s First 7F-Compatible Balloon Guide Catheter for Neurovascular Use
Lake Forest, CA – Crossroads Neurovascular, Inc. is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K242392) for its groundbreaking PATH BGC™, a next-generation balloon guide catheter (BGC) designed to advance neurovascular intervention. With this clearance, PATH BGC becomes the world’s first BGC […]
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard® Prime EPS.
Viz.ai Receives First and Only FDA 510(k) Clearance for Subdural Measurements
SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural Plus, the first and only comprehensive solution for quantifying the size of collections like subdural hemorrhages (SDH) in the subdural space […]
Philips launches intelligent 3D imaging in Europe to empower faster stroke care, helping physicians save time, brain, and lives
Demonstrated at LINNC Paris 2025, the company’s latest release of SmartCT delivers fast, intelligent 3D imaging in the Angio suite — helping physicians act with greater speed and confidence during a range of critical neurovascular procedures
Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter
Terumo Neuro’s SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility PARIS, June 2, 2025 /PRNewswire/ — Terumo Neuro, a global leader in…
Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke Conference
New evidence from the largest prospective evaluation of stroke AI imaging further validates Brainomix 360 Stroke impact on mechanical thrombectomy, expanding patient access across networks to the life-changing treatment The Oxford-based pioneer continues to drive cutting-edge research…



